Enovis (ENOV) Short-term Investments (2017 - 2022)
Enovis' (ENOV) quarterly Short-term Investments came in at $200.3 million in Q3 2022, down 23.88% quarter-over-quarter from $263.1 million in Q3 2022.
Powered by 
Analysis
Enovis (ENOV) Short-term Investments (2017 - 2022) Analysis & Trends
Enovis (ENOV) has reported Short-term Investments for 2 consecutive years, with $200.3 million the latest figure, recorded in Q3 2022.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $200.3 million in Q3 2022; TTM through Sep 2022 was $200.3 million, a N/A change from a year earlier, with the FY2017 full-year figure at $149.6 million, changed N/A from the prior year.
- Short-term Investments was $200.3 million for Q3 2022 at Enovis, down from $263.1 million in the prior quarter.
- Over five years, Short-term Investments peaked at $263.1 million in Q3 2022 and troughed at $200.3 million in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 200.27 Mn |
| Jul 1, 2022 | 263.10 Mn |
| Dec 31, 2017 | 149.61 Mn |